Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07585513 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Beta-3 Enhanced Autonomic Therapy for POTS

Name: Beta-3 Enhanced Autonomic Therapy for POTS — clinical trial record (NCT07585513)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: BEAT-POTS

StatusNot Yet Recruiting

PhasePhase 2

SponsorCedars-Sinai Medical Center

Started2026-05

View on ClinicalTrials.gov ↗

Cedars-Sinai Medical Center

133 trials monitored

See 15 trials at risk

The study will test the hypothesis that mirabegron is more effective than a placebo in alleviating postural orthostatic tachycardia (POTS) symptoms.

Trial Details

NCT Number	NCT07585513
Lead Sponsor	Cedars-Sinai Medical Center
Conditions	Postural Orthostatic Tachycardia Syndrome (POTS)
Enrollment	36 participants
Start Date	2026-05
Primary Completion	2028-05 (estimated)
Study Completion	2028-05 (estimated)
Updated on ClinicalTrials.gov	2026-05-13